SLC39A13

solute carrier family 39 member 13, the group of Solute carrier family 39

Basic information

Region (hg38): 11:47407132-47416496

Links

ENSG00000165915NCBI:91252OMIM:608735HGNC:20859Uniprot:Q96H72AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • spondyloepimetaphyseal dysplasia-abnormal dentition syndrome (Definitive), mode of inheritance: AR
  • Ehlers-Danlos syndrome, spondylocheirodysplastic type (Definitive), mode of inheritance: AR
  • Ehlers-Danlos syndrome, spondylocheirodysplastic type (Strong), mode of inheritance: AR
  • Ehlers-Danlos syndrome, spondylocheirodysplastic type (Strong), mode of inheritance: AR
  • Ehlers-Danlos syndrome, spondylocheirodysplastic type (Strong), mode of inheritance: AR
  • Ehlers-Danlos syndrome, spondylocheirodysplastic type (Supportive), mode of inheritance: AR
  • Ehlers-Danlos syndrome, spondylocheirodysplastic type (Limited), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Ehlers-Danlos syndrome, spondylodysplastic type, 3ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Dermatologic; Musculoskeletal18985159; 18513683

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SLC39A13 gene.

  • Ehlers-Danlos syndrome, spondylocheirodysplastic type (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC39A13 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
4
clinvar
89
clinvar
1
clinvar
94
missense
88
clinvar
3
clinvar
3
clinvar
94
nonsense
1
clinvar
2
clinvar
3
start loss
0
frameshift
2
clinvar
2
inframe indel
1
clinvar
3
clinvar
4
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
8
15
1
24
non coding
2
clinvar
53
clinvar
15
clinvar
70
Total 1 1 102 145 19

Variants in SLC39A13

This is a list of pathogenic ClinVar variants found in the SLC39A13 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
11-47408638-G-C not specified Likely benign (Oct 23, 2017)512793
11-47408639-G-T not specified Likely benign (Mar 09, 2018)390363
11-47408641-T-TCGC Benign (May 30, 2018)517012
11-47408665-G-A Ehlers-Danlos syndrome Uncertain significance (Dec 11, 2020)1702276
11-47408665-G-T Uncertain significance (May 30, 2017)432424
11-47408907-T-C Benign (Jun 23, 2018)1239745
11-47408918-T-C Ehlers-Danlos syndrome, spondylocheirodysplastic type Uncertain significance (Jan 22, 2021)2436025
11-47409739-T-G Benign (Aug 07, 2018)1241668
11-47409752-A-G Likely benign (Jul 14, 2018)1189899
11-47409959-C-T Likely benign (Jul 14, 2018)1215474
11-47409978-G-A Benign (Jun 26, 2018)1277095
11-47410014-G-A Benign (Aug 12, 2018)1285981
11-47410069-G-T not specified Likely benign (Nov 28, 2017)513624
11-47410071-C-A not specified Likely benign (Nov 13, 2017)513330
11-47410116-G-A Inborn genetic diseases Uncertain significance (Mar 15, 2024)3319751
11-47410117-G-T Ehlers-Danlos syndrome, spondylocheirodysplastic type • Inborn genetic diseases Uncertain significance (May 03, 2023)1476405
11-47410125-A-G Ehlers-Danlos syndrome, spondylocheirodysplastic type • Inborn genetic diseases Uncertain significance (Feb 23, 2023)1512991
11-47410126-T-C Inborn genetic diseases Uncertain significance (Feb 07, 2023)2481815
11-47410129-C-T Ehlers-Danlos syndrome, spondylocheirodysplastic type Uncertain significance (Aug 04, 2023)652451
11-47410130-G-A Ehlers-Danlos syndrome, spondylocheirodysplastic type Likely benign (Feb 23, 2023)2859110
11-47410132-G-C Ehlers-Danlos syndrome, spondylocheirodysplastic type Uncertain significance (May 17, 2021)1213030
11-47410132-G-T Ehlers-Danlos syndrome, spondylocheirodysplastic type Uncertain significance (Aug 24, 2021)1010781
11-47410133-C-T Ehlers-Danlos syndrome, spondylocheirodysplastic type Likely benign (Dec 24, 2021)737744
11-47410145-C-T Ehlers-Danlos syndrome, spondylocheirodysplastic type Likely benign (Jan 04, 2024)2713436
11-47410149-C-T Ehlers-Danlos syndrome, spondylocheirodysplastic type Uncertain significance (Aug 07, 2022)597727

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SLC39A13protein_codingprotein_codingENST00000362021 99365
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.002510.9841257070291257360.000115
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.261702230.7630.00001462347
Missense in Polyphen4874.6570.64294851
Synonymous-0.2751081041.030.00000768819
Loss of Function2.16716.40.4268.04e-7181

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002490.000246
Ashkenazi Jewish0.000.00
East Asian0.0002240.000217
Finnish0.000.00
European (Non-Finnish)0.0001430.000141
Middle Eastern0.0002240.000217
South Asian0.0001310.000131
Other0.0001650.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Acts as a zinc-influx transporter. {ECO:0000269|PubMed:21917916}.;
Disease
DISEASE: Ehlers-Danlos syndrome, spondylodysplastic type, 3 (EDSSPD3) [MIM:612350]: A form of Ehlers-Danlos syndrome, a group of connective tissue disorders characterized by skin hyperextensibility, articular hypermobility, and tissue fragility. EDSSPD3 is an autosomal recessive form characterized by a generalized skeletal dysplasia involving mainly the spine and striking clinical abnormalities of the hands, in addition to classic features of Ehlers-Danlos syndrome. Clinical features include postnatal growth retardation, moderate short stature, protuberant eyes with bluish sclerae, hands with finely wrinkled palms, atrophy of the thenar muscles, and tapering fingers. Radiologic features include mild to moderate platyspondyly, mild to moderate osteopenia of the spine, small ileum, flat proximal femoral epiphyses, short, wide femoral necks, and broad metaphyses (elbows, knees, wrists, and interphalangeal joints). {ECO:0000269|PubMed:18513683}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Nuclear Receptors Meta-Pathway;NRF2 pathway;Zinc homeostasis (Consensus)

Recessive Scores

pRec
0.124

Intolerance Scores

loftool
0.656
rvis_EVS
0.98
rvis_percentile_EVS
90.38

Haploinsufficiency Scores

pHI
0.308
hipred
N
hipred_score
0.242
ghis
0.419

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.485

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Slc39a13
Phenotype
cellular phenotype; craniofacial phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; skeleton phenotype; vision/eye phenotype;

Gene ontology

Biological process
cellular zinc ion homeostasis;response to zinc ion;connective tissue development;zinc ion transmembrane transport
Cellular component
endoplasmic reticulum;Golgi apparatus;integral component of membrane;integral component of Golgi membrane;perinuclear region of cytoplasm
Molecular function
zinc ion transmembrane transporter activity;protein binding;protein homodimerization activity